Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of PARPs and ADP-ribosylation on inflammation and host–pathogen interactions
Anthony R. Fehr, Sasha A. Singh, Catherine M. Kerr, et al.
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 341-359
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
Mario Mehmel, Nina Jovanović, Urs Spitz
Nutrients (2020) Vol. 12, Iss. 6, pp. 1616-1616
Open Access | Times Cited: 181
Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity
Collin D. Heer, Daniel J. Sanderson, Lynden S. Voth, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 52, pp. 17986-17996
Open Access | Times Cited: 164
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
M. Schuller, G.J. Correy, Stefan Gahbauer, et al.
Science Advances (2021) Vol. 7, Iss. 16
Open Access | Times Cited: 161
Novel insights on the pulmonary vascular consequences of COVID-19
François Potus, Vicky Mai, Marius Lebret, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 319, Iss. 2, pp. L277-L288
Open Access | Times Cited: 149
Protein post-translational modifications in the regulation of cancer hallmarks
Haiying Wang, Liqian Yang, Minghui Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 529-547
Closed Access | Times Cited: 79
β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice
Hui-ru Li, Qiang Liu, Cheng‐long Zhu, et al.
Redox Biology (2023) Vol. 63, pp. 102745-102745
Open Access | Times Cited: 46
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
Pulak Kar, Chatrin Chatrin, N Mimica Dukic, et al.
The EMBO Journal (2024) Vol. 43, Iss. 14, pp. 2929-2953
Open Access | Times Cited: 15
The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase
Yousef M. Alhammad, M.M. Kashipathy, Anuradha Roy, et al.
Journal of Virology (2020) Vol. 95, Iss. 3
Open Access | Times Cited: 121
PARPs in lipid metabolism and related diseases
Magdolna Szántó, Rebecca Gupte, W. Lee Kraus, et al.
Progress in Lipid Research (2021) Vol. 84, pp. 101117-101117
Open Access | Times Cited: 100
The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation
Yousef M. Alhammad, Anthony R. Fehr
Viruses (2020) Vol. 12, Iss. 4, pp. 384-384
Open Access | Times Cited: 99
DNA Damage Response and Immune Defense
Claudia Nastasi, Laura Mannarino, Maurizio D’Incalci
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7504-7504
Open Access | Times Cited: 98
Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis
Ramesh Kumar, Divya Mehta, Nimisha Mishra, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 323-323
Open Access | Times Cited: 95
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling
Lilian C. Russo, Rebeka Tomasin, Isaac de Araújo Matos, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 3, pp. 101041-101041
Open Access | Times Cited: 95
Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential
J.G.M. Rack, Valentina Zorzini, Zihan Zhu, et al.
Open Biology (2020) Vol. 10, Iss. 11
Open Access | Times Cited: 76
The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism
Magdolna Szántó, Péter Bai
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 321-340
Open Access | Times Cited: 71
ADP-ribosylation of RNA and DNA: fromin vitrocharacterization toin vivofunction
Lisa Weixler, Katja Schäringer, Jeffrey Momoh, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 7, pp. 3634-3650
Open Access | Times Cited: 67
Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targets
Kelsie M. Rodriguez, Sara C. Buch-Larsen, Ilsa T. Kirby, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 63
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 39
NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
Gabriela Fabiana Soares Alegre, Gláucia María Pastore
Current Nutrition Reports (2023) Vol. 12, Iss. 3, pp. 445-464
Open Access | Times Cited: 35
ATP ion channel P2X purinergic receptors in inflammation response
Jipeng Liu, Si-cheng Liu, Shiqi Hu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114205-114205
Open Access | Times Cited: 30
A viral ADP-ribosyltransferase attaches RNA chains to host proteins
Maik Wolfram-Schauerte, Nadiia Pozhydaieva, Julia Grawenhoff, et al.
Nature (2023) Vol. 620, Iss. 7976, pp. 1054-1062
Open Access | Times Cited: 29
Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6519-6536
Closed Access | Times Cited: 9
Repositioning PARP inhibitors for SARS‐CoV‐2 infection(COVID‐19); a new multi‐pronged therapy for acute respiratory distress syndrome?
Nicola J. Curtin, Krisztiàn Bányai, James Thaventhiran, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 16, pp. 3635-3645
Open Access | Times Cited: 62
CD38 in the age of COVID-19: a medical perspective
Alberto L. Horenstein, Angelo Corso Faini, Fabio Malavasi
Physiological Reviews (2021) Vol. 101, Iss. 4, pp. 1457-1486
Open Access | Times Cited: 47
Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
Xiaomin Ni, Martin Schröder, Vincent Oliéric, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 4, pp. 603-609
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top